Tuesday, 12 November 2019

Drug Discovery Informatics Market Profile | Dynamics and Key Players | Forecast To 2023

The Global Drug Discovery Informatics Market held a value of USD 1,680.6 million in 2017 and is projected to grow at a CAGR of 11.5% over the forecast period. Drug discovery and development is an extremely complex process requiring the generation of very large amounts of information data and. As the pharmaceutical and biotechnology industry is on the rise, information technology is supporting the drug discovery process to improve research productivity and success rates. Patent expiry of blockbuster drugs, an over-reliance on high throughput discovery strategies, and ongoing industry consolidation through mergers and acquisitions (M&A) are fueling the demand for drug discovery informatics.

Few of the market growth factors include a worldwide rising focus on drug discovery, growing need to control drug discovery and development costs, rising research and development (R&D) expenditure, and increasing burden of chronic diseases. For instance, according to the Association of the British Pharmaceutical Industry (ABPI), the global pharmaceutical industry invested more than USD 1.36 trillion in R&D from 2007 to 2016, and it is projected to an annual investment of USD 181 billion by 2022. In contrast, high pricing and setup cost of informatics software is anticipated to limit the market growth during the forecast period.


Introduction of in-silico tools that facilitate computation with varied workflows that are in sync with the rate of modern medicinal chemistry is one of the key trends augmenting market growth. It involves different steps and procedures which depend on in-silico tools for reducing the complexity of the process. In-silico tools include modeling tools for the determination of 3D structures of ligand and protein-absorption, distribution, metabolism, excretion, and toxicity (ADMET) assessment-affinity estimation in docking and drug-ligand interaction for pharmacological profiling.

Drug Discovery Informatics Market Segmentation:
The global drug discovery informatics market has been segmented into product, mode, service, end user, and region.
By product, the market has been segmented into discovery informatics and development informatics.
On the basis of mode, the market has been divided into in-house informatics and outsourced informatics. 
By service, the market has been classified into sequencing and target data analysis, docking, molecular modeling, clinical trial data management, and others. The sequencing and target data analysis segment is expected to dominate the market over the forecast period due to rising application of informatics solutions in targeted analysis and a large amount of data generated during the drug discovery process.
Based on end user, the market has been categorized into pharmaceutical and biotechnology industries, contract research organizations (CROs), and others.


Drug Discovery Informatics Market Key Players:
Few of the foremost players in the global drug discovery informatics market are Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Certara, L.P., Infosys Limited, Novo Informatics Pvt. Ltd., Collaborative Drug Discovery Inc., Selvita, Charles River Laboratories, Inc., International Business Machines Corporation, Jubilant Life Sciences Ltd., IO Informatics, Inc., GVK Biosciences Private Limited, and Dassault Systèmes.

Brows More Healthcare Related Market Research Reports:
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
at No comments:

Healthcare Regulatory Affairs Outsourcing Market Trend Analysis | Supply and Segmentation | Forecast To 2023

The Global Healthcare Regulatory Affairs Outsourcing Market held a value of USD 3,120.4 million in 2017 and is projected to grow at a CAGR of 9.4% over the forecast period. The healthcare regulatory affairs outsourcing offers medical writing and publishing which plays an important role to develop high-quality documents for the clinical research process. The rising, increasing number of patent expirations and growing research and development activities are some factors that are likely to propel the market growth during the assessment period.
Additionally, the rising incidence of several chronic diseases such as cancer and other infectious diseases have encouraged biopharmaceutical companies to develop many new products. This rising development of products in clinical trials, the demand for clinical trial application and product registration services is increasing, thus driving the growth of this market.


For instance, the International Federation of Pharmaceutical Manufacturers & Associations stated that around 1,919 and 1,308 drugs are in development for cancer and neurology, respectively. Additionally, IFPMA stated that in 2014, there were 401 drugs in the pipeline for diabetes and 208 drugs in development for HIV/AIDS. Furthermore, IFPMA specified that their members have 119 ongoing R&D projects related to neglected tropical diseases.
On the other hand, the risk associated with data security and lack of standardization may hamper the market growth during the assessment period.

Currently, the global healthcare regulatory affairs outsourcing market is dominated by numerous prominent players. The key players operating in this market offer comprehensive knowledge in managing healthcare regulatory affairs. These companies mainly intend to help firms overcome challenges and accelerate clinical processes.
On a regional basis, the global healthcare regulatory affairs outsourcing market in the Americas is segmented into two major regions, i.e., North America and Latin America. The North American region is likely to hold the major share in the region is due to the increasing prevalence of chronic diseases. The rising prevalence of cancer and other chronic diseases demands the discovery of newer and effective drugs which is anticipated to fuel the market growth in this region.


For instance, according to the Centers for Disease Control and Prevention, in 2014, 9,421 new cases of tuberculosis were registered in the US. Moreover, according to the National Cancer Institute, in 2016, around 1,685,210 new cases of cancer had been diagnosed in the US.

Brows More Healthcare Related Market Research Reports:
About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com


at No comments:

Surgical Snare Market SWOT Analysis | Capacity and Opportunities | Forecast To 2023

Market Highlights
The Global Surgical Snare Market size is expected to grow at an approximate CAGR of 4.4% during the forecast period, 2018–2023. A surgical snare is a wire hoop use to tighten polyps or small tumors for severing, especially in body cavities. Surgical snares are extensively utilized in endoscopy. From the past few years, the market has grown with a rapid pace owing to the increasing number of endoscopy procedures, growing geriatric population, and rising healthcare expenditure.

According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), about 30 to 40 percent of people in the United States get an H. pylori infection which is the cause of peptic ulcers. However, factors such as low per capita income and lack of skilled workforce are estimated to restraint the market growth. World Health Organization (WHO) estimates that based on a threshold of 4.4 skilled health professionals per 1000 population, the needs-based shortage of health-care workers globally would be about 17.4 million of which almost 2.6 million are doctors and over 9 million are nurses and midwives.


Segmentation
The global surgical snare market is segmented based on usability, application, end user, and region.
On the basis of usability, the global surgical snare market is segmented into reusable and single use. By application, the global surgical snare market by application is categorized into laparoscopy, endoscopy, cystoscopy, otoscopy, laryngoscopy, neuroendoscopy, and others. By end-user, the global surgical snare market is categorized into hospitals & clinics, ambulatory surgical centers, and others.

Regional Analysis
The Americas dominates the global market owing to the rising occurrence of diseases, high healthcare expenditure and well-developed healthcare infrastructure. In the United States, the annual spending on GI diseases is estimated to be nearly USD 140 billion. Following similar trends, Europe stands second in the market. Rising geriatric population is estimated to fuel the market.


Asia-Pacific was the fastest growing region for the global surgical snare market in 2017. Factors such as increasing innovation and awareness about the available treatment. On the other hand, the Middle East and Africa holds the least share in the global surgical snare market owing to the presence of poor economies and low per capita income, especially within the African region. Most of the market share within this region is estimated to be held by the Middle East.  

Brows More Healthcare Related Market Research Reports:
About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

at No comments:

Home Infusion Therapy Devices Market Insights | Dynamics and Growth | Forecast To 2024

The Global Home Infusion Therapy Devices Market held a market value of USD 20.1 Billion in 2017 and is projected to grow at a CAGR of 7.1% by 2024. Home infusion therapy devices are devices that are used to deliver medications through a needle or catheter into a vein inside the home setting.

Home Infusion Therapy Devices Market Segmentation
The global home infusion therapy devices market has been segmented into product and application.
By product, the market has been segmented into infusion pumps, intravenous sets, IV cannulas, needleless connectors, elastomeric pumps, and others. The intravenous sets segment is expected to register the highest CAGR during the forecast period due to growing demand.

Based on application, the market has been segmented into anti-infectives, endocrinology, enteral nutrition, chemotherapy, hydration therapy, parenteral infusion, and others.


Home Infusion Therapy Devices Market Key Players
Some of the prominent players in the global home infusion therapy devices market are B. Braun Melsungen AG, Fresenius Kabi AG, Baxter International Inc., Johnson & Johnson Private Limited, Pfizer Inc., Terumo Corporation, Smith & Nephew, and Care Fusion Corporation.

Home Infusion Therapy Devices Market Regional Analysis
On a regional basis, the Americas is anticipated to dominate the global home infusion therapy devices market owing to the owing to increasing geriatric population, high prevalence of various chronic diseases, and many diagnostic imaging centers. Additionally, many surgical procedures, along with the fast adoption of technologically advanced home care products is driving the growth of the market. For instance, according to the Center for Diseases Control and Prevention, approximately 46.5 million surgical procedures are performed every year in the US. Additionally, according to the United States Census Bureau, around 49.2 million adults aged 65 and above were present in the US as of 2016.

Europe accounts for the second largest market and holds a healthy share in the global home infusion therapy devices market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, and flourishing medical device industry due to the presence of major market players.


Asia-Pacific is expected to be the fastest growing market, owing to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, and availability of favorable insurance policies.

The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access, and availability of treatment facilities. In the Middle East, the UAE and Saudi Arabia is the largest market share owing to the development of the healthcare industry and the rising availability of specialty care centers.

Brows More Healthcare Related Market Research Reports:
About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
at No comments:

Over-the-wire Micro Guide Catheters Market Size | Trends and Share | Forecast To 2023

According to Market Research Future (MRFR), the global Over-the-wire Micro Guide Catheters market is expected to grow at a CAGR of 9.37% during the forecast period (2018–2023). Over-the-wire Micro Guide Catheter (OTW Micro Guide Catheter) is a thin tubular Medical device inserted into the body for diagnosis or treatments of diseases like cardiovascular, neurovascular, and urology. Specially designed to ease complex procedures, OTW Micro Guide Catheter combining excellent cross-ability and optimal guide-wire support, can effectively treat challenging cases involving tortuous vessels, CTO (chronic total occlusions), bifurcations, and highly stenosed and calcified lesions, giving the high success rate.

OTW Catheters are widely used in cardiovascular applications such as peripheral and coronary interventions and neurovascular interventional applications. The high success rate associated with the use of these catheters further augments its uptake and demand, resultantly driving its market growth.
According to reports published by the Centers for Disease Control and Prevention, the coronary heart disease is the most common type of heart diseases that accounted for the death of about 366,000 people in 2015.
Over-the-wire catheters comparatively make a better choice to treat a brain aneurysm than the rapid exchange catheters owing to their capabilities of extra pushing to enter stenose vessels, and additional support that they provide.

The increasing occurrences of coronary heart diseases, neurovascular diseases, hypertension, and other metabolic disorders, raising awareness for health, advancement in technologies, good healthcare infrastructure, and favorable reimbursement policies are fueling the market growth. 


Over-the-wire Micro Guide Catheters Market Regional Analysis
The global over-the-wire micro guide catheters market is segmented into four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas is the global market leader for over-the-wire Micro-guide catheters. As per the study published in the Surgical Neurology International in 2017, it was found that more than 3% population of the United States equivalent to nearly 10 million individuals have a brain aneurysm. North America commands for the major share of the market whereas; South America show the fastest growth of the market due to the presence of boundless growth opportunities.

Europe OTW Micro Guide Catheter market holds the second position, globally. This is primarily attributable to the increasing prevalence of obesity as well as the increased incidence rate of hypertension and diabetes, which in turn is escalating cardiovascular traumas and cardiac arrest. Each year 15% of deaths in Europe occur due to cardiovascular diseases claims a study conducted by European Society of Cardiology.

The Asia Pacific region is the fastest growing market for the over-the-wire micro guide catheters. The region presents significant growth opportunities for market players as local policy makers continue to restructure the policy framework for the healthcare sector.


Global OTW Micro Guide Catheter Market: Segmentation
The global over-the-wire micro guide catheters market is segmented based on applications and end-users. Based on applications, it is segmented into cardiovascular and neurovascular. By the cardiovascular, it is segmented into angiography, angioplasty, peripheral stenting, and others. Based on the neurovascular, it is segmented into intracranial aneurysms, percutaneous neurointerventional procedures, and others. Based on end-user the market is segmented into hospitals & clinics, ambulatory surgical centers, research & academic institutes, and others.  

Major Players in the Over-the-wire Micro Guide Catheters Market
Enki – Microtubes, Cardinal Health, DePuy Synthes, Koninklijke Philips N.V, Penumbra Inc., Terumo Europe N.V., Integer Holdings Corporation, Merit Medical Systems Inc., Teleflex Incorporated, Cook Medical, Boston Scientific Corporation, Asahi Intecc Company Limited, and Medtronic plc.

Brows More Healthcare Related Market Research Reports:
About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
at No comments:

Ultra-Low Temperature Freezer Market Share | Growth and Size | Forecast To 2024

Ultra-Low Temperature Freezer Market Size, Growth and Share Analysis By Type (Upright Ultra-Low Temperature Freezer and Chest Ultra-Low Temperature Freezer), Leading Key Players and Regions, Forecast To 2024

The Global Ultra-Low Temperature Freezer Market is Estimated to be valued at USD 897.28 million by 2024 and is expected to register a CAGR of 3.20% during the forecast period.

Ultra-low temperature freezer is designed to store biological samples such as drugs, enzymes, cell preparations, chemicals, viruses, bacteria, tissue samples, and others at constant temperatures from -86°C down to -150°C. These laboratory freezers are available in different sizes and used according to the requirement.

The Americas accounted for the largest Ultra-low temperature freezer market share of 46.18% in 2017, with a market value of USD 343.04 Million; the market is expected to register a CAGR of 3.30% during the forecast period. Europe was the second-largest market in 2017, valued at USD 208.06 Million; the market is projected to exhibit a CAGR of 3.21%. However, the market in Asia-Pacific is expected to register the highest CAGR of 3.41%.


Ultra-Low Temperature Freezer Market Players
Market Research Future (MRFR) recognizes Thermo Fisher Scientific Inc., Helmer scientific, Stirling Ultracold, Global Cooling Inc, Eppendorf AG., VWR International, PHC Corporation, Esco Micro Pte Ltd., BINDER GmbH, Labcold and Arctiko as the key players in the global ultra-low temperature freezer market.

Ultra-Low Temperature Freezer Market Segmentation:
The Global The ultra-low temperature (ULT) freezer market has been segmented on the basis of type and end user.
There are two major designs for ultra-low temperature freezers with both having different sizes relying upon the storage and accessible impression space.

By type, the ultra-low temperature (ULT) freezer is segmented into upright ultra-low temperature (ULT) freezer and chest ultra-low temperature (ULT) freezer.
An end user is a biomedical personnel or industry that ultimately consumes the product. Usually, the end user does not have a technical understanding of the product or how it has been developed. 


By end-user, the global ultra-low temperature freezer market is segmented into biobanks, hospitals and clinics, academic and research laboratories, and others. There is a high demand for ultra-low temperature freezers from end users as there is a constant increase in research activities in the biomedical industry, and these freezers are used to preserve the samples at very low temperature. The bio-banks segment accounted for the largest ultra-low temperature freezer market share of 46.03% in 2018, with a market value of USD 341.89 Million; it is expected to register the highest CAGR of 3.40% during the forecast period. The hospitals & clinics segment was the second-largest market in 2018, valued at USD 222.54 Million; it is projected to exhibit a CAGR of 3.29%.

Brows More Healthcare Related Market Research Reports:
About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
at 1 comment:

Insulin Delivery Devices Market Profile | Trend and SWOT Analysis | Forecast To 2025

Insulin Delivery Devices Market Analysis By Type (Insulin Pen, Insulin Syringes Insulin Pumps, Insulin jet injectors, Pen Needles), Distribution Channel, End User, Region, Leading Companies, Size Analysis, Share Value and Emerging Trends Till 2025

The Global Insulin Delivery Devices Market size and share is estimated to reach USD 21.8 billion with growing at a CAGR of 7.85% during the forecast period of 2019 to 2025. Insulin Delivery Devices Providing treatment with the help of various devices like pen injectors, insulin pumps, jet injectors and insulin syringe.
Insulin delivery devices market is anticipated to grow swiftly due to increasing awareness among the people concerning diabetic care, widespread occurrence of diabetes, rising obesity endemic and technological advancements regarding delivery devices. Diabetes is a chronic disease wherein the body fails to produce the requisite amount of insulin or is unable to use the same in an effective manner. Diabetes comprises primarily of two types, namely type 1 and type 2. This disorder occurs when the blood sugar or blood glucose level in the body is way to high.


Insulin Delivery Devices Market Competitive Landscape

The Global Insulin Delivery Devices Market hosts several key and prominent players, including
  • MannKind
  • SHL Group
  • Medtronic
  • Copernicus
  • InsuJet
  • Becton Dickinson (BD)
  • Beta Bionics
  • Roche
  • Sanofi
  • Novo Nordisk
  • Eli Lilly
Insulin Delivery Devices Market Segmentation
The Global Insulin Delivery Devices Market segmented on the basis of
  • Type
  • Distribution Channel
  • End User
Insulin Delivery Devices Market has been segmented on the basis of type into
  • Insulin pumps
  • Insulin syringes
  • Insulin jet injectors
  • Insulin pens
  • Others
While each one of these devices are effective and hold key attributes, the market category is led by insulin pumps.
Insulin pumps are projected to be a significant segment in the coming years and is expected to drive notable revenues towards the global insulin delivery devices market. It is further expected that the introduction of advanced insulin delivery devices like portable insulin pumps will be the key factor in the insulin delivery devices market growth in next few years.


Insulin Delivery Devices Market Regional Analysis
The Global Insulin Delivery Devices Market is geographically segmented into North America, Europe, Asia Pacific, and Rest-of-the-World (RoW).
America
  • North America
  • US
  • Canada
  • South America
Europe
  • Western Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest Of Western Europe
  • Eastern Europe
Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Republic Of Korea
  • Rest Of Asia Pacific
Middle East & Africa
  • United Arab Emirates
  • Saudi Arabia
  • Oman
  • Kuwait
  • Qatar
  • Rest Of Middle East & Africa
Table of Content
  • Executive Summary
  • Market Introduction
  • Research Methodology
  • Market Dynamics
  • Market Factor Analysis
  • Global Insulin Delivery Devices Market, by Type
  • Global Insulin Delivery Devices Market, by Distribution Channel
  • Global Insulin Delivery Devices Market, by End-User
  • Global Insulin Delivery Devices Market, by Region
  • Company Landscape
  • Company Profiles
  • Appendix
  • List Of Tables
  • List Of Figures
Brows More Healthcare Related Market Research Reports:
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +16468459312
Email: sales@marketresearchfuture.com

at No comments:
Subscribe to: Posts (Atom)

Ultra-low Temperature Freezers Market Profile, Trends and Applications By 2027

  According to the MRFR reports, the global   ultra-low temperature freezers market   is projected to acquire a market size of approximately...